Regular Hours
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
| Valuation Estimation |
|
EPS (Current/Estimated)
-3.87/-1.50
|
|
Enterprise Value
9.69M
|
| Balance Sheet |
|
Book Value Per Share
1.01
|
| Cash Flow |
|
Cash Flow Yield
--
|
| Income Statement |
|
Total Revenue
3.19M
|
|
Operating Revenue Per Share
0.50
|
|
Industry Comparison
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Quotes are at least 15-min delayed:2025/11/19 22:33 EST
Industry overview quotes are at least 15 minutes delayed
|
Business Description
|
|||
| Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. |

0.808099 
